Global market for autoimmune treatments to grow to $55 billion by 2016

The global market for autoimmune treatments reached $34 billion in 2010 and is expected to reach $38.9 billion by 2011.  It will further grow to $55 billion by 2016 at a compounded annual growth rate (CAGR) of 7.2%. The U.S is the largest market for autoimmune treatments and holds a 43% share of the global market. It will sustain its position and will hold a 44% share in 2016.

Learn about the products and therapies currently used or under development for treatment of a variety of autoimmune diseases. Also learn about the global autoimmune market by product segment, disease, and geographical region. Company profiles are provided as well...

Use this report to:

• Receive in-depth analysis and forecasts of the global autoimmune products market
• Determine products and therapies currently used or under development for treatment of a variety of autoimmune diseases
• Understand the autoimmune market by disease and by treatment, with supporting tables and figures to illustrate projected growth
• Analyze information on autoimmune treatment assistive technologies, patents and regulations.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

GLOBAL MARKET FOR AUTOIMMUNE TREATMENTS BY GEOGRAPHICAL AREA, 2011 AND 2016

(%)

Global market for drugs used to treat liver disease to grow to $14.2 billion by 2016

In 2010, the global market for drugs used to treat liver disease was worth $12.4 billion. The estimated sales for 2011 were approximately $12 billion (excluding protease inhibitors) and are expected to rise at a compound annual growth rate (CAGR) of 3.3% to reach $14.2 billion by 2016.

Learn about the present and future strategies within the liver disease drug market, including market sizes, market leaders, market overview, and various other market factors, as well as the market for end users. Companies that manufacture and sell new and innovative liver disease-related drugs are profiled as well...

Use this report to:

• Gain an overview of the current and future characteristics of the global market for liver disease drugs, including the market for end users
• Learn about different categories of liver disease drugs and the various types of liver disease broken down by market shares belonging to leading manufacturers and/or suppliers
• Gain information regarding different liver disease drugs in response to an increasing need for new and innovative drug treatments
• Analyze the market leaders, regulatory environment, technology, market projections, and market shares of the liver disease drug industry.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

GLOBAL REVENUE FOR DRUGS USED TO TREAT LIVER DISEASES BY REGION, 2009-2016

($ MILLIONS)

Source: BCC Research